The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug ...

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...

Osaka Metropolitan University scientists have developed an artificial photosynthesis technology that produces precursors of ...

This stage does not require oxygen. If oxygen is available to the cell then the pyruvate molecules can be further broken down in stage two to release more energy and produce a greater quantity of ATP.